Trial Profile
A pilot study: Levetiracetam in the treatment of patients with premenstrual dysphoric disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2014
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Premenstrual dysphoric disorder
- Focus Therapeutic Use
- 30 Aug 2007 New trial record.